US Stock MarketDetailed Quotes

Ocular Therapeutix (OCUL)

Watchlist
  • 8.940
  • +0.240+2.76%
Close Jun 12 16:00 ET
  • 8.890
  • -0.050-0.56%
Post 19:56 ET
1.96BMarket Cap-6.21P/E (TTM)

About Ocular Therapeutix Company

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Company Profile

SymbolOCUL
Company NameOcular Therapeutix
Listing DateJul 25, 2014
Issue Price13.00
ISINUS67576A1007
Founded2006
CEODr. Pravin U. Dugel, M.D.
MarketNASDAQ
Employees274
Fiscal Year Ends12-31
Address15 Crosby Drive
CityBedford
ProvinceMassachusetts
CountryUnited States of America
Zip Code01730
Phone1-781-357-4000
Websitehttp://www.ocutx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Pravin U. Dugel, M.D.
  • Chairman of the Board, President and Chief Executive Officer
  • 35.95M
  • Jason Shand Robins
  • Interim Chief Financial Officer and Principal Accounting Officer
  • --
  • Donald Notman
  • Chief Financial Officer, Chief Operating Officer and Principal Accounting Officer
  • 3.67M
  • Namrata Saroj
  • Chief Business Officer
  • --
  • Todd Anderman
  • Chief Legal Officer and Secretary
  • --
  • David Wayne Robinson
  • Global Chief Commercial Officer
  • --
  • Dr. Sanjay Nayak, M.B.B.S.,PhD
  • Chief Strategy Officer
  • 3.46M
  • Dr. Peter Kaiser, M.D.
  • Chief Development Officer
  • --
  • Dr. Nadia Waheed, M.D.
  • Chief Medical Officer
  • 4.38M
  • Dr. Jeffrey S. Heier, M.D.
  • Chief Scientific Officer
  • --
  • Merilee Raines
  • Independent Director
  • 463.68K
  • Leslie J. Williams
  • Independent Director
  • 461.18K
  • Charles Warden
  • Lead Independent Director
  • 498.68K
  • Dr. Seung Suh Hong, PhD
  • Independent Director
  • 448.68K
  • Dr. Richard L. Lindstrom,M.D.
  • Independent Director
  • 461.18K
  • Dr. Adrienne L. Graves,PhD
  • Independent Director
  • 448.68K
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +11.05%
Sample Name
Sample Code
 +1.03%
Sample Name
Sample Code
 -2.29%
4
VanEck Oil Services ETF
OIH
-3.00%
5
ProShares Ultra Energy
DIG
-3.15%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.02%
Sample Name
Sample Code
 +9.96%
Sample Name
Sample Code
 +9.80%
4
Qifu Technology
QFIN
+5.99%
5
Futu Holdings Ltd
FUTU
+5.64%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran peace talks have entered a critical window! On the 14th, Iranian sources indicated that Pakistan will host a video conference Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -